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Stable hypercapnic COPDAbstract Background: Chronic obstructive pulmonary disease (COPD) is a disease with progres-
sive course of dyspnea which leads to reduced health related quality of life (HRQoL). Exercise
training has useful effects toward their exercise tolerance and health related quality of life
(HRQoL). However extreme breathlessness limits these patients in maintaining exercise training.
Non-invasive positive pressure ventilation (NIPPV) is considered a beneﬁcial treatment option
for chronic stable hypercapnic respiratory failure. So, the aim of this study is to assess the effect
of adding NIPPV to Exercise training program compared to Exercise training program alone in sta-
ble hypercapnic COPD patients.
Patients and methods: Thirty patients with stable hypercapnic COPD were selected, subdivided
into two groups; 15 patients underwent Exercise training alone (Ex. group) and another 15 patients
performed Exercises training in association with receiving NIPPV (Ex. + NIPPV group). Baseline
and after 3 months assessment of arterial blood gases analysis (ABGs), pulmonary function tests
(PFTs), dyspnea scale by modiﬁed Medical Research Council (mMRC) and assessment of HRQoL
guided by COPD Assessment Test (CAT) were done for both groups.
Results: In the Exercise training group, they showed statistical signiﬁcant improvement in dyspnea
scale (mMRC) and CAT score after 3 month performance (p< 0.05), but insigniﬁcant changes
occurred in their ABGs or PFTs (p> 0.05). While in the Ex. + NIPPV group, a highly statistical
signiﬁcant improvement regarding PCO2, FEV1 and dyspnea scale (mMRC) (p 6 0.001) and a signif-
icant difference as regards HRQoL assessment score (p< 0.05) were found after 3 month follow up.
Conclusion: Addition of NIPPV to exercise training in patients with stable hypercapnic COPD
patients improved PCO2, FEV1, dyspnea scale and HRQoL.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.d.
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Chronic obstructive pulmonary disease (COPD) is one of the
leading causes of death worldwide [1]. Patients with severe
COPD often develop chronic hypercapnic respiratory failure
with a worse prognosis and more frequent exacerbations
[2]. Even during stable states and with optimal medications,
these patients are always suffering from dyspnea which is a
very common complaint especially during physical activities
[3].
This leads to chronic physical inactivity, exercise intoler-
ance and sedentary life style, with more ventilation
demands feeding the dyspnea-inactivity-dyspnea cycle [4].
Among the wide range of non-pharmacological therapeutic
approaches for stable COPD, starting from smoking cessa-
tion, long term oxygen therapy (LTOT) [5], pulmonary
rehabilitation [6] and ending with Bronchoscopic lung vol-
ume reduction [7], there are still a few interventions which
diminish the number of exacerbations and improve survival
[8].
Exercise training as a part of multidisciplinary pulmonary
rehabilitation (PR) has useful effects toward exercise tolerance
and health related quality of life in stable COPD patients [9].
These effects underwent via reduction of lactic acidosis, minute
ventilation, heart rate and enhance the activity of mitochon-
drial enzymes with increased capillary density in the trained
muscles [10], However extreme breathlessness limits these
patients in maintaining exercise training [10]. Therefore, there
is a need for additive therapies enhancing the effectiveness of
PR [11].
Non-invasive positive pressure ventilation (NIPPV) is con-
sidered a beneﬁcial treatment option for chronic stable hyper-
capnic respiratory failure [12].
A number of positive effects have been documented dur-
ing NIPPV; it improved gas exchange, unloaded respiratory
muscles and reset the central respiratory drive [13]. Clinical
manifestations of these physiologic changes are reﬂected as
reduced dyspnea, improved health related quality of live
(HRQoL) [14], and potentiated the beneﬁts of rehabilitation
program [15].
The effect of NIPPV in association with multidisciplinary
pulmonary rehabilitation program in chronic stable COPD
had been investigated by different studies, but with different
contradictory results. Garrod et al. [16], Kohnlein et al. [17]
and Duiverman et al. [18], had assessed the effect of combina-
tion of NIPPV and PR but in short term interval. Other studies
used low ventilator pressure settings which resulted in unben-
eﬁcial effect [19].
So, the aim of this study is to assess the effect of adding
NIPPV to Exercise training program compared to Exercise
training program alone in stable hypercapnic COPD patients
for a period of 3 months.
Patients and methods
This study was conducted at (Chest, Rheumatology and
Rehabilitation) Departments and outpatient clinics Faculty
of Medicine, Zagazig University hospitals in the period from
October 2012 till April 2014. Written informed consents were
obtained from all patients. The study was approved by the
local ethics committee of the institute.Patients
Thirty patients were selected with severe and very severe COPD
(GOLD 3 and GOLD 4) with Forced expiratory volume in 1st
second/Forced vital capacity (FEV1/FVC) <70% and FEV1
<50% predicted [20], associated with day time hypercapnia
(PaCO2 P50 mmHg) and stable clinical condition (no exacer-
bation for the prior four weeks with (pHP 7.35) [21], receiving
proper medications according to GOLD 2011 [20]. They were
20 males and 10 females with age range 66.05 ± 9.4 years.
They were subdivided into two groups:
Exercise Training group (Ex): 15 patients performed Exer-
cise training.
Exercises training + NIPPV (Ex. + NIPPV): 15 patients
performed exercise training in association with NIPPV in
the form of BiPAP home mechanical ventilation.
Exclusion criteria were: After invasive mechanical
ventilation, obstructive sleep apnea [8], cardiac diseases
limiting exercise tolerance [11], neuromuscular diseases [18]
or orthopedic impairment of shoulder girdle [4].
Method
All patients were subjected to:
(1) Thorough medical history taking.
(2) General and local chest examination.
(3) Chest X-ray (posteroanterior and lateral views).
(4) Arterial blood gases analysis (ABGs).
(5) Routine laboratory investigations:
– Complete blood count
– Liver function tests
– Kidney function tests(6) ECG.
(7) Pulmonary function tests (PFTs):
All patients underwent spirometric PFT with reversibility
testing after inhalation of short acting B2-agonist (200 lg
salbutamol) of metered-dose inhaler. PFT was done using
ZAN-100 (ﬂow HANDY II) pulmonary function appara-
tus. The following parameters were assessed as absolute
values and percentage of predicted post bronchodilator:
Forced expiratory volume in 1st second (FEV1), Forced
vital capacity (FVC) and (FEV1/FVC) ratio.
(8) Assessment of health related quality of life (HRQoL) by
using COPD Assessment Test (CAT) [22,23]:
This score included eight items assessing: cough, phlegm,
chest tightness, breathlessness going up a hill/stairs, activity
limitations at home, conﬁdence leaving home, sleep and
energy. Each item was scored from 0 to 5 giving a total
score from 0 to 40, corresponding to the best and worst
health status in patients with COPD. Scores of 0–10, 11–
20, 21–30 and 31–40 represented mild, moderate, severe
or very severe clinical impact, respectively.
(9) Assessment of dyspnea level by modiﬁed Medical
Research Council (mMRC) dyspnea scale [20]:
It is a 5-point scale from 0 to 4 based on levels of dyspnea
according to patient’s response, describing dyspnea from
none (Grade 0) to almost complete incapacity (Grade 4).
Table 1 Demographic data of the studied groups.
Parameter (Ex.) group
no. = 15
(Ex. + NIPPV)
group no. = 15
P-value
Age (years) 66.41 ± 9 65.70 ± 10 0.84
Sex: M/F 11/4 9/6 0.43
BMI (kg/m2) 25 ± 7 26 ± 4 0.49
LTOT (no., %) 4 (26.6%) 5 (33.4%) 0.62
Table 2 Baseline ABGs, PFTs, mMRC and CAT of the
studied groups.
Parameter (Ex.) group
no. = 15
(Ex. + NIPPV)
group no. = 15
P-value
ABGs
pH 7.38 ± 0.02 7.38 ± 0.03 0.71
PaCO2 (mmHg) 57.7 ± 6.8 58.3 ± 5.6 0.79
PaO2 (mmHg) 59.1 ± 4.2 58.5 ± 5.8 0.74
PFTs
FEV1 (% pred.) 35.7 ± 7.3 34.4 ± 5.8 0.54
FVC (% pred.) 52.3 ± 7.5 52.4 ± 2.0 0.82
FEV1/FVC (%) 45.8 ± 9.3 46.6 ± 1.8 0.57
Dyspnea scale (mMRC) 2.8 ± 0.6 2.9 ± 0.9 0.26
CAT 29 ± 4.2 27 ± 4.4 0.22
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Before starting Exercise training to (Ex. + NIPPV) group,
15 patients were admitted to Chest Department for at least
2–3 days and instituted on NIPPV (Bilevel positive airway
pressure (BiPAP), Spontaneous/time mode (S/T), using
nasal or full face mask) [11] (Sunrise Medical, Somerset,
PA 15501-2125, USA). Inspiratory positive airway pressure
(IPAP) is gradually increased till reaching 15–20 cmH2O
[21] and Expiratory positive airway pressure (EPAP)
3–6 cmH2O [24], this titration is stopped prior to the point
where the patient cannot tolerate. When patient accommo-
dates BiPAP >5 h during the day [8], nocturnal BiPAP
ventilation started for 9 ± 2 h/night [2]. This occurs under
careful supervision of SPO2, respiratory rate, heart rate.
Patient was discharged to continue at home mechanical
ventilation BiPAP device. In case of fulﬁlling criteria of
requiring long term oxygen therapy (LTOT) according to
GOLD (2011), NIPPV was administrated with additional
oxygen delivered by using a cannula attached to a port in
the nasal masks till reaching SPO2 P90% [25].
(11) Exercise training:
All patients involved in the study underwent Exercise
training program in the form of 12 weeks of physical
training, 2 times a week at Rehabilitation Unit in the
Rheumatology and Rehabilitation Department, Zagazig
University Hospitals. Each training session lasted
approximately 30–35 min, divided as: 8 min breathing exercises in the form of forced expi-
ration, slow and deep breathing, pursed lips breath-
ing and diaphragmatic breathing [26], each is
repeated 10 times.
 8 min shoulder wheel exercise, aiming to increase the
mobility of the chest and thus increasing the respi-
ratory capacity [27].
 8 min of electrical stimulation of both quadriceps
muscles, to improve muscle strength and exercise p-
erformance [28]
 8 min walks or riding a stationary bicycle or a tread-
mill [29] as preferred by each patient.Table 3 Baseline ABG analysis, PFTs, mMRC, CAT and
after 3 months in the exercise training group.
Parameter At baseline After 3 months P-value
ABGs
pH 7.38 ± 0.02 7.38 ± 0.04 0.81
PCO2 (mmHg) 57.7 ± 6.8 56.6 ± 5.3 0.96
PO2 (mmHg) 59.1 ± 4.2 59.7 ± 3.4 0.63
PFTs
FEV1 (% pred.) 35.7 ± 7.3 35.7 ± 8.6 0.84
FVC (% pred.) 52.3 ± 7.5 53.4 ± 9.1 0.72
FEV1/FVC (%) 45.8 ± 9.3 47.3 ± 2.4 0.45
Dyspnea scale (mMRC) 2.8 ± 0.6 2.3 ± 0.7 0.002
CAT 29 ± 4.2 23 ± 2.2 0.03End point of the study:
(1) Intolerance
(2) Death
Statistical analysis
Data were checked, entered and analyzed by using SPSS ver-
sion 19. Data represented as number and percentage for cate-
gorical variables, Chi-squared (v2) or Fisher’s exact test were
used when appropriate, p< 0.05 was considered statistically
signiﬁcant.
Results
This study included 30 patients with stable hypercapnic COPD
with mean age 66.15 ± 9.3. They were 20 males and 10
females. They were divided into; Exercise training group (15
patients) and Exercise training in association with NIPPVgroup (15 patients). Patients were followed up after 3 months
with recorded changes regarding ABGs, PFTs, mMRC and
CAT score.
The socio-demographic data of both groups are shown in
Table 1. The two groups were matched for age, sex, BMI,
and number of patients receiving LTOT (P> 0.05). There
were non-signiﬁcant differences between the two groups
regarding baseline recorded ABGs, PFTs, mMRC and CAT
score at the start of the study with p> 0.05 (Table 2).
In the Ex-group, there were non-signiﬁcant differences of
ABGs, PFTs at baseline and after 3 months (P> 0.05), while
a statistically signiﬁcant improvement in mMRC and CAT
score was found after 3 months (p= 0.02 and 0.03, respec-
tively) (Table 3). As shown in Table 4, a highly statistically sig-
niﬁcant decrease in PCO2 and a highly statistically signiﬁcant
increase in FEV1 after 3 months in the Ex. + NIPPV group
(p= 0.00 and 0.001, respectively) were observed. However,
there was an improvement in PH, PO2, FVC and
FEV1/FVC but this improvement did not reach statistically
signiﬁcant levels. Besides, there was a statistically signiﬁcant
Table 4 Basline ABGs, PFTs, mMRC, CAT and after
3 months of performing exercise training and receiving NIPPV.
Parameter At baseline After 3 months P-value
ABGs
pH 7.38 ± 0.03 7.40 ± 0.03 0.56
PCO2 (mmHg) 58.3 ± 5.6 47.3 ± 4.7 0.00
PO2 (mmHg) (58.5 ± 5.8) 61.3 ± 7.1 0.27
PFTs
FEV1 (% pred.) 34.4 ± 5.8 42.3 ± 6.5 0.001
FVC (% pred.) 52.4 ± 2.0 54.2 ± 3.1 0.06
FEV1/FVC (%) 46.6 ± 1.8 48.7 ± 3.8 0.15
Dyspnea scale (mMRC) 2.9 ± 0.9 2.1 ± 0.72 0.00
CAT 27 ± 4.4 20.2 ± 1.4 0.02
Table 5 Changes in ABGs, PFTs, mMRC, CAT after
3 months in both groups.
Parameter (Ex.) group
no. = 15
(Ex. + NIPPV)
group no. = 15
P-value
ABGs
PH 7.38 ± 0.04 7.40 ± 0.03 0.39
PCO2 (mmHg) 56.6 ± 5.3 47.3 ± 4.7 0.001
PO2 (mmHg) 60.5 ± 1.3 61.3 ± 7.1 0.32
PFTs
FEV1 (% pred.) 35.7 ± 8.6 42.3 ± 6.5 0.02
FVC (% pred.) 53.4 ± 9.1 54.2 ± 3.1 0.57
FEV1/FVC (%) 47.3 ± 2.4 48.5 ± 3.8 0.21
Dyspnea scale (mMRC) 2.3 ± 0.7 2.1 ± 0.72 0.01
CAT 23 ± 2.2 20.2 ± 1.4 0.01
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which was high and HRQoL guided by CAT score
(P= 0.00 and 0.002, respectively).
Comparison between the two groups regarding changes in
ABGs, PFTs, mMRC and CAT after 3 months revealed a
highly statistically signiﬁcant decrease in PCO2 (p= 0.01) with
a non-signiﬁcant difference regarding both PH and PO2
(p> 0.05) in the Ex. + NIPPV group. Also, a signiﬁcant
increase in FEV1 (p= 0.02), with non-signiﬁcant changes in
FVC and FEV1/FVC were observed in the same group.
Besides, a signiﬁcant improvement in mMRC and CAT score
was detected in patients of the Ex. + NIPPV group (P= 0.01)
(Table 5).
Discussion
COPD is a disease with progressive course of dyspnea which
leads to reduced health related quality of life and high mortal-
ity rate [18].
Exercise training remains the cornerstone of rehabilitation
programmes and offers beneﬁts to exercise tolerance that are
complementary to the effects of pharmacotherapy in COPD
management [30]. However in severe COPD rehabilitation
program may be difﬁcult to be maintained, therefore there is
a need for additive therapies like NIPPV. NIPPV has effect
in resting the respiratory muscles [31], improving lung mechan-
ics [32] and improving ventilation during the day [33].
So, this study was designed to assess the role of NIPPV in
addition to exercise training compared to exercise trainingalone and their impact on HRQoL, gas exchange and pulmon-
ary functions in stable hypercapnic COPD patients.
In the current study assessment of HRQoL was done using
COPD Assessment Test (CAT). Dodd et al. [34] had intro-
duced CAT instrument to assess COPD HRQoL after rehabil-
itation program. They emphasized from their results of study
that CAT is a robust and practical alternative to Chronic
Respiratory Questionnaire-Self Report (CRQ-SR).
Another study performed by Ringbaek et al. [23] had
reported a good correlation between CAT, St George’s Respi-
ratory questionnaire (SGRQ), and COPD Clinical Question-
naire (CCQ) in assessment of COPD after PR, furthermore
CAT and CCQ showed more advantage of being easier and
faster to complete than SGRQ especially in those patients with
low education level.
In the current study, exercise training group, has a signiﬁ-
cant improvement in dyspnea scale assessed by mMRC and
HRQoL guided by CAT with P< 0.05, while pulmonary
function tests (PFTs) and blood gases had no signiﬁcant
changes after completing 3 month exercise training
(P> 0.05) (Table 3). This result is in accordance with that
of Hui et al. [35], Hildegrade et al. [36] and Spencer et al.
[37] who found no changes in PFTs while dyspnea and
HRQoL had a signiﬁcant improvement. Suh et al. [14] had
explained this result as ; during exercise training there is
improvement in skeletal muscle performance and reduced lac-
tate production which enhances the relationship between respi-
ratory muscle load and capacity. This is achieved through
modiﬁcations in breathing pattern with optimization of pul-
monary mechanics, and reduction in exertion related dyspnea
with further improvement in skeletal muscle performance.
Also, in the present study, addition of NIPPV to exercise
training compared to exercise training alone for 3 months
had improved PFTs, blood gases, dyspnea and HRQoL in
patients with stable hypercapnic COPD. Signiﬁcant decline
of PCO2 in the Ex. + NIPPV group than those of the exercise
training group was observed (56.6 ± 5.3 versus 47.3 ± 4.7)
(P= 0.01) (Table 5). On the other hand pH values were
improved in the previous group but this improvement did
not reach a statistically signiﬁcant level (7.38 ± 0.04 versus
7.40 ± 0.03) (P= 0.39) (Table 5).
Similar results were demonstrated by Nava et al. [31],
Wijkstra [1], Duiverman et al. [11], Backer et al. [8] and
Duiverman et al. [18], results of study. On the other hand
Garrod et al. [16] disagreed with our results, they concluded
no changes regarding ABGs. This difference may be attributed
to their usage of short duration of NIPPV (2.08 h/day) and the
inclusion of mild chronic respiratory failure (mean PaCO2
6.0 kPa or 45 mmHg), while our study involved COPD
patient with grade III or IV severity spending 9 ± 2 hrs/day
on NIPPV with PaCO2 P50 mmHg. In the same way
Mezzanotte et al. [38] demonstrated no beneﬁts on gas
exchange as they had a short follow up time 2 weeks. Other
contradictory results were introduced by Casanova et al.
[25]. This difference is attributed to their usage of low pres-
sures of NIPPV (IPAP: 12 cmH2O, EPAP: 4 cmH2O).
Struik et al. [39] recommended from their results of study
that higher IPAP levels, more ventilated hours with higher
PaCO2 baseline, all improve PaCO2 after 3 months on NIPPV.
As regards PFTs, the Ex. + NIPPV group showed
improvement in FEV1 than the exercise training group alone
with P= 0.02 while FVC, FEV1/FVC were improved but
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were in accordance with Duiverman et al. [18] who reported
a signiﬁcant change in FEV1 in NIPPV + PR more than PR
alone. They explained this improvement in FEV1 either by vol-
ume expansion and/or a decrease in airﬂow obstruction. Burns
and Gibson [40] postulated that reduction in hypercapnia
aided by NIPPV leads to a decrease in airway edema via reduc-
ing salt and water retention. Windisch et al. [41], Dreher et al.
[42] and Schonhofer [19] speculated from their studies that
using high inﬂation pressure causing signiﬁcant reduction in
hypercapnia is essential for improvement in pulmonary
functions.
Furthermore, Windisch et al. [24] explained a relation
between hypercapnia and dilatation of precapillary sphincters
which is believed to be a permanent factor of airway edema, So
improvement in FEV1 is related to lowering PaCO2 level.
As for dyspnea assessment: mMRC scale was signiﬁcantly
improved in the Ex. + NIPPV group than that of the exercise
training group alone (2.3 ± 0.7 versus2.1 ± 0.72) (P= 0.01)
(Table 5). This result agreed with that of Duiverman et al.
[18]. It was in contrast with Pessoa et al. [4] who reported that
dyspnea score was increased after performing upper limb exer-
cises with NIPPV. This result indicates indirectly an overload
of the respiratory muscles which is attributed to; 1) applica-
tions of low pressures (IPAP = 10) and (EPAP = 4), low
EPAP pressure was insufﬁcient to counter balance intrinsic
positive end expiratory pressure (iPEEP) with more load on
the inspiratory muscles. 2) the application of upper limb exer-
cises as reported by many results of studies [43–45] that COPD
patients always complaining from more dyspnea after per-
forming prolonged tasks with unsupported elevated upper
limbs compared to lower limb exercises. This fact demon-
strates the possibility of upper limb exercises to generate
greater dynamic hyperinﬂation than lower limb exercises.
In the current study HRQoL assessed by CAT in the
Ex. + NIPPV group improved than those of exercise group
alone with signiﬁcant changes (23 ± 2.2 versus 20.2 ± 1.4)
(P= 0.01) (Table 5). Duiverman et al. [18] disagreed with
our results of study and explained the disimprovement in
HRQoL to the debate of using chronic respiratory question-
naire (CRQ) as an optimum instrument for dyspnea assess-
ment in chronic respiratory failure.
On the other hand, Windisch et al. [46], Duiverman et al.
[11] and McEvoy et al. [12] documented from their studies
an improvement of HRQoL using Maugeri Respiratory Fail-
ure-28 (MRF 28) and Severe Respiratory Insufﬁciency ques-
tionnaires while others using St. George’s Respiratory
questionnaire reported no changes or more worsened HRQoL
after NIPPV. So using of disease speciﬁc tool, is more appro-
priate and useful one [15].
In patients with stable hypercapnic respiratory failure, the
combination of night time non-invasive ventilation and day
time pulmonary rehabilitation had many beneﬁcial effects
[30]. The former intervention has a mechanical effect of blow-
ing air into the lungs over a longer period which leads to better
perfused area resulting in more efﬁcient gas exchange [8].
Exercise training reverses the systemic consequences of
COPD mainly skeletal muscle dysfunction, via enhancing the
mechanical efﬁcacy of physical activities, improves oxidative
capacity, enhances the anabolic process in skeletal muscles
and reduces the perception of dyspnea [30].Conclusion
Addition of NIPPV to exercise training in patients with stable
hypercapnic COPD improved PCO2, FEV1, dyspnea scale and
HRQoL.
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